The drug also isn't expected to have the same supply constraints as injectable GLP-1 drugs, which need specialized injection pens as well ... On the day of Eli Lilly's earnings report, CVS Health ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Shares of Eli ... injection pens as well as cold storage and shipping. Orforglipron won't require either of these things, making its manufacturing and transport a lot easier. Lilly has also ...

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

Eli Lilly, the manufacturer of Zepbound, made Zepbound available on its online pharmacy, LillyDirect, in August 2024. The medication is available as a single-dose vial or an auto-injector pen.

The study involved a large clinical trial comparing the drugs that was funded by Eli Lilly, the maker of Zepbound ... Mr. Whitrap said. Image An injection pen for Zepbound, which Caremark intends ...

If approved, the less burdensome version of Leqembi could be used to treat patients at home or in medical facilities, help Eisai and Biogen differentiate Leqembi from Eli Lilly's recently approved ...

Getting your hands on a popular weight loss drug is about to get a lot cheaper and easier, especially if you don't have insurance. WeGovy will soon be available at a reduced cost of $499 a month ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...